2. Gene
  3. Flt3 - Fms related receptor tyrosine kinase 3 Gene

Flt3 - Fms related receptor tyrosine kinase 3 Gene

  • Gene
  • Protein
  • Agent
  • Ortholog
Rattus norvegicus
Gene ID: 140635 | Gene type: protein coding

About Flt3

Primary_assembly 12: 7,623,930-7,699,474 forward strand.mRatBN7.2:CM026985.1

This gene has 1 transcript (splice variant), 134 orthologues, 54 paralogues and is associated with 26 phenotypes. Biased expression in Spleen (RPKM 69.2), Brain (RPKM 39.3) and 7 other tissues.

Summary

Enables Glucocorticoid Receptor binding activity. Involved in animal organ regeneration; cellular response to glucocorticoid stimulus; and response to organonitrogen compound. Located in cytosol; nucleus; and plasma membrane. Part of protein-containing complex. Human ortholog(s) of this gene implicated in acute lymphoblastic leukemia; acute myeloid leukemia; colorectal adenocarcinoma; hepatocellular carcinoma; and prostate Cancer. Orthologous to human FLT3 (fms related receptor tyrosine kinase 3). [provided by Alliance of Genome Resources, Apr 2022]

Flt3 Products(1)

mRNA Protein Name
NM_001100822.3 NP_001094292.1 receptor-type tyrosine-protein kinase FLT3 precursor

Flt3 Protein Structure

ig

ig: pfam00047 (254 - 344)

PKc_like

PKc_like: cl21453 (571 - 948)

  • 0
  • 200
  • 400
  • 600
  • 800
  • 1000 a.a.
Protein Preferred Names Protein Names

receptor-type tyrosine-protein kinase FLT3

FL cytokine receptor

FMS-like tyrosine kinase 3

fms-related tyrosine kinase 3

Related Agents

Approval
Bioactive Molecules (14)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-10201 Sorafenib Inhibitor 99.92% Yes
HY-13016 Cabozantinib Inhibitor 99.96% Yes
HY-12432 Gilteritinib Inhibitor 99.88% Yes
HY-13001 Quizartinib Inhibitor 99.01% Yes
HY-16379 Pacritinib Inhibitor 99.93% Yes
HY-10201A Sorafenib Tosylate Inhibitor 99.91% Yes
HY-13038A Fostamatinib Inhibitor 99.50% Yes
HY-112306 Ripretinib Inhibitor 99.33% Yes
HY-10201S Sorafenib-d3 Inhibitor 99.57% Unkown
HY-13038 Fostamatinib Disodium Inhibitor 99.88% Yes
HY-12432A Gilteritinib hemifumarate Inhibitor 99.75% Yes
HY-13038B Fostamatinib disodium hexahydrate Inhibitor 99.73% Yes
HY-13016A Cabozantinib hydrochloride Inhibitor / Unkown
HY-16379A Pacritinib hydrochloride Inhibitor / Unkown
Clinical Phase
Bioactive Molecules (32)
Cat. No. Product Name Effect
Purity Phase
HY-50751 Linifanib Inhibitor 99.28% Phase 3
HY-50905 Dovitinib Inhibitor 99.94% Phase 3
HY-16961 Sitravatinib Inhibitor 99.59% Phase 3
HY-50867 Lestaurtinib Inhibitor 99.17% Phase 3
HY-10207 Dovitinib lactate Inhibitor 99.62% Phase 3
HY-16961A Sitravatinib malate Inhibitor / Phase 3
HY-B0062 Dovitinib lactate hydrate Inhibitor / Phase 3
HY-13024 Rebastinib Inhibitor 99.91% Phase 2
HY-135317 Emavusertib Inhibitor 99.96% Phase 2
HY-50514 AT9283 Inhibitor 99.70% Phase 2
HY-13034 Gandotinib Inhibitor 99.82% Phase 2
HY-15514 Merestinib Inhibitor 99.99% Phase 2
HY-10206 Amuvatinib Inhibitor 99.47% Phase 2
HY-10987A ENMD-2076 Inhibitor 99.12% Phase 2
HY-10202 Tandutinib Inhibitor 99.48% Phase 2
HY-100867A TAK-659 hydrochloride Inhibitor 99.91% Phase 2
HY-145015 Tuspetinib Inhibitor 99.77% Phase 2
HY-10987 ENMD-2076 Tartrate Inhibitor 99.42% Phase 2
HY-15514A Merestinib dihydrochloride Inhibitor 99.36% Phase 2
HY-10202A Tandutinib hydrochloride Inhibitor 99.78% Phase 2
HY-118304B AKN-028 acetate Inhibitor 99.95% Phase 2
HY-100867 TAK-659 Inhibitor / Phase 2
HY-10206A Amuvatinib hydrochloride Inhibitor / Phase 2
HY-118304 AKN-028 Inhibitor / Phase 2
HY-10339 KW-2449 Inhibitor 99.69% Phase 1
HY-101549 MRX-2843 Inhibitor 99.70% Phase 1
HY-B0791 Altiratinib Inhibitor 98.05% Phase 1
HY-111361 FN-1501 Inhibitor 99.08% Phase 1
HY-10032 PF 477736 Inhibitor 99.21% Phase 1
HY-139535 Luxeptinib Inhibitor 99.30% Phase 1
HY-13072 Cenisertib Inhibitor 99.64% Phase 1
HY-19897 4SC-203 Inhibitor 99.87% Phase 1
Pre-clinical Phase
Bioactive Molecules (121)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-12067 R406 Inhibitor 98.72% Unkown
HY-13223 Crenolanib Inhibitor 99.68% Yes
HY-12344 UNC2025 Inhibitor 99.83% Unkown
HY-15166 (E/Z)-Zotiraciclib Inhibitor 99.96% Unkown
HY-13263 CHIR-124 Inhibitor 98.57% Unkown
HY-11108 R406 free base Inhibitor 99.80% Unkown
HY-15002 AST 487 Inhibitor 99.42% Unkown
HY-10410 TG101209 Inhibitor 99.22% Unkown
HY-12344A UNC2025 hydrochloride Inhibitor 99.87% Unkown
HY-153886 Wu-5 Inhibitor 99.34% Unkown
HY-N0071 Crotonoside Inhibitor 99.64% Unkown
HY-13894 Tyrphostin AG1296 Inhibitor 99.69% Unkown
HY-12333 Denfivontinib Inhibitor ≥98.0% Unkown
HY-15889 AMG 925 Inhibitor 98.20% Unkown
HY-12420 JNJ-47117096 hydrochloride Inhibitor 99.68% Unkown
HY-145723 MAX-40279 Inhibitor 97.10% Unkown
HY-132200 UNC5293 Inhibitor 95.07% Unkown
HY-120758 SEL24-B489 Inhibitor 98.58% Unkown
HY-114323 PROTAC FLT-3 degrader 1 Inhibitor 99.74% Unkown
HY-153857 PHI-101 Inhibitor 98.97% Unkown
HY-130247 JAK2/FLT3-IN-1 Inhibitor 99.79% Unkown
HY-131906 JAK2-IN-7 Inhibitor 99.15% Unkown
HY-18161 CCT241736 Inhibitor 98.09% Unkown
HY-130247A JAK2/FLT3-IN-1 TFA Inhibitor 99.77% Unkown
HY-15166B (E/Z)-Zotiraciclib citrate Inhibitor 98.06% Unkown
HY-18952A (Z)-SU5614 Inhibitor 98.43% Unkown
HY-13907 TCS 359 Inhibitor 99.89% Unkown
HY-15166A (E/Z)-Zotiraciclib hydrochloride Inhibitor 99.45% Unkown
HY-15003 ATH686 Inhibitor 99.38% Unkown
HY-13493 AC710 Inhibitor 98.56% Unkown
HY-13016S Cabozantinib-d6 Inhibitor 98.14% Unkown
HY-18744 FLT3-IN-2 Inhibitor 98.38% Unkown
HY-120590 Ruserontinib Inhibitor 99.82% Unkown
HY-13537A BPR1J-097 Hydrochloride Inhibitor 99.20% Unkown
HY-107417 Hypothemycin Inhibitor ≥98.0% Unkown
HY-144869 OTS447 Inhibitor 99.83% Unkown
HY-162037 CDDD11-8 Inhibitor 99.62% Unkown
HY-132150A HPK1-IN-2 dihydrochloride Inhibitor 98.69% Unkown
HY-112145 FLT3-IN-3 Inhibitor 99.73% Unkown
HY-151904 AXL-IN-13 / Unkown
HY-15889A AMG 925 HCl Inhibitor / Unkown
HY-12960 SKLB4771 Inhibitor 98.08% Unkown
HY-18179 AZD2932 Inhibitor 99.04% Unkown
HY-100865 BPR1K871 Inhibitor 98.45% Unkown
HY-128572 FLT3-IN-6 Inhibitor 99.14% Unkown
HY-128571 FLT3-IN-4 Inhibitor 98.19% Unkown
HY-15198 KG5 Inhibitor 99.79% Unkown
HY-108263 3-Hydroxy Midostaurin Inhibitor 97.02% Unkown
HY-134481 FLT3-IN-10 Inhibitor 98.80% Unkown
HY-143286A PF15 TFA Degrader 99.72% Unkown
HY-124502 UNC4203 Inhibitor 99.80% Unkown
HY-153473 FLT3-IN-19 Inhibitor 99.19% Unkown
HY-148070 FLT3-IN-17 Inhibitor 99.56% Unkown
HY-13537 BPR1J-097 Inhibitor / Unkown
HY-12432S1 Gilteritinib-d8 Inhibitor ≥98.0% Unkown
HY-135317B Emavusertib hydrochloride Inhibitor / Unkown
HY-146749 FLT3/TrKA-IN-1 Inhibitor / Unkown
HY-111545 BSc5371 Inhibitor / Unkown
HY-15496 E6201 Inhibitor / Unkown
HY-145723B MAX-40279 hemifumarate Inhibitor 99.56% Unkown
HY-145015A Tuspetinib hydrate Inhibitor / Unkown
HY-145723A MAX-40279 hydrochloride Inhibitor / Unkown
HY-145723C MAX-40279 hemiadipate Inhibitor 99.26% Unkown
HY-155341 HSK205 Inhibitor / Unkown
HY-145904 PDGFRα/FLT3-ITD-IN-3 Inhibitor / Unkown
HY-144711 FLT3/ITD-IN-3 Inhibitor / Unkown
HY-144709 FLT3/ITD-IN-1 Inhibitor / Unkown
HY-143286 PF15 Inhibitor / Unkown
HY-155112 Antiproliferative agent-30 Inhibitor / Unkown
HY-161323 FLT3-ITD/D835Y-IN-1 Inhibitor / Unkown
HY-158325 PROTAC FLT-3 degrader 4 Inhibitor / Unkown
HY-148521 PROTAC FLT3/CDK9 degrader-1 Degrader / Unkown
HY-155302 FLT3-IN-22 Inhibitor / Unkown
HY-161280 PROTAC FLT-3 degrader 3 Degrader / Unkown
HY-112475 Flt-3 Inhibitor III Inhibitor / Unkown
HY-149539 PLM-101 Inhibitor / Unkown
HY-103464 5'-Fluoroindirubinoxime Inhibitor ≥98.0% Unkown
HY-139619 LT-850-166 Inhibitor / Unkown
HY-148036 FLT3-IN-16 Inhibitor 98.98% Unkown
HY-144710 FLT3/ITD-IN-2 Inhibitor / Unkown
HY-15519 LBW242 Inhibitor / Unkown
HY-145690 HP1328 Inhibitor / Unkown
HY-143894 FLT3-IN-11 Inhibitor / Unkown
HY-155594 LT-540-717 Inhibitor / Unkown
HY-150582 c-Met-IN-14 Inhibitor / Unkown
HY-50905S Dovitinib-d8 Inhibitor / Unkown
HY-157213 LWY713 Degrader / Unkown
HY-149474 HDAC-IN-63 Inhibitor / Unkown
HY-155226 FLT3-IN-21 Inhibitor / Unkown
HY-146680 FLT3/ITD-IN-4 Inhibitor / Unkown
HY-162367 FLT3/CHK1-IN-2 Inhibitor / Unkown
HY-151961 RSH-7 Inhibitor 99.07% Unkown
HY-115906 K783-0308 Inhibitor / Unkown
HY-143895 FLT3-IN-12 Inhibitor / Unkown
HY-146886 FLT3-IN-15 Inhibitor / Unkown
HY-108263S 3-Hydroxy Midostaurin-d5 Inhibitor / Unkown
HY-156410 FLT3-IN-23 Inhibitor / Unkown
HY-18949 JI6 Inhibitor / Unkown
HY-151945 TRK II-IN-1 Inhibitor / Unkown
HY-143434 FLT3/D835Y-IN-1 Inhibitor / Unkown
HY-10201S2 Sorafenib-13C,d3 Inhibitor 98.35% Unkown
HY-108263A (S)-3-Hydroxy Midostaurin Inhibitor / Unkown
HY-10201S1 Sorafenib-d4 Inhibitor / Unkown
HY-144777 FLT3-IN-14 Inhibitor / Unkown
HY-162032 FLT3-IN-25 Inhibitor / Unkown
HY-110026 GTP-14564 Inhibitor 99.91% Unkown
HY-145902 PDGFRα/FLT3-ITD-IN-1 Inhibitor / Unkown
HY-148522 FLT3-IN-18 Inhibitor / Unkown
HY-110293 CHMFL-FLT3-122 Inhibitor / Unkown
HY-108263B (R)-3-Hydroxy Midostaurin Inhibitor / Unkown
HY-163068 FLT3-IN-24 Inhibitor / Unkown
HY-13016S1 Cabozantinib-d4 Inhibitor / Unkown
HY-155770 FLT3-IN-20 Inhibitor / Unkown
HY-111249 TTT 3002 Inhibitor / Unkown
HY-145691 HP1142 Inhibitor / Unkown
HY-115904 FLT3/CDK4-IN-1 Inhibitor / Unkown
HY-145903 PDGFRα/FLT3-ITD-IN-2 Inhibitor / Unkown
HY-143278 FLT3-IN-13 Inhibitor / Unkown
HY-10058 AT9283 lactic acid Inhibitor / Unkown
HY-16379B Pacritinib citrate Inhibitor / Unkown
HY-15163 Zotiraciclib Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Flt3 NCBI NCBI:2322
Macaca fascicularis Flt3 NCBI NCBI:102144988
Mus musculus Flt3 NCBI NCBI:14255
Susscrofa domestica Flt3 NCBI
Macaca mulatta Flt3 NCBI NCBI:721712